Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review
Flavia Lo Castro,1 Simona Guerzoni,1 Lanfranco Pellesi2 1Medical Toxicology, Headache and Drug Abuse Research Center, Department of Specialized Medicine, AOU Policlinico di Modena, Modena, Italy; 2Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical...
Guardado en:
Autores principales: | Lo Castro F, Guerzoni S, Pellesi L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/052562f361c14f4fa8681714a9809356 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review
por: Alison M. Deighton, et al.
Publicado: (2021) -
Letter to the Editor: The Case for Publicly Funded Headache Surgery in Germany
por: Leonard Knoedler, et al.
Publicado: (2021) -
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
por: Stephanie J. Nahas, et al.
Publicado: (2021) -
The journal of headache and pain
Publicado: (2000) -
Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies
por: Timothy R. Smith, et al.
Publicado: (2021)